ESPERION
Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called "HDL Therapy," which is based on the Company's understanding of high-density lipoprotein, or HDL, function.
ESPERION
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1998-01-01
Address:
Ann Arbor, Michigan, United States
Country:
United States
Website Url:
http://www.esperion.com
Total Employee:
101+
Status:
Active
Contact:
734-332-0506
Total Funding:
764.15 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy DNS ReCAPTCHA V2 Microsoft
Similar Organizations
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oberland Capital
Oberland Capital investment in Post-IPO Equity - Esperion
Longitude Capital
Longitude Capital investment in Venture Round - Esperion
Aisling Capital
Aisling Capital investment in Venture Round - Esperion
Domain Associates
Domain Associates investment in Venture Round - Esperion
Alta Partners
Alta Partners investment in Venture Round - Esperion
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Venture Round - Esperion
Arboretum Ventures
Arboretum Ventures investment in Venture Round - Esperion
Arboretum Ventures
Arboretum Ventures investment in Series A - Esperion
Alta Partners
Alta Partners investment in Series A - Esperion
Domain Associates
Domain Associates investment in Series A - Esperion
Official Site Inspections
http://www.esperion.com Semrush global rank: 4.34 M Semrush visits lastest month: 2.63 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Esperion"
FAQs - Esperion Therapeutics, Inc.
Computershare P.O. Box 43006 Providence, RI 02940-3006 Phone: 877-373-6374See details»
Esperion Therapeutics - Wikipedia
The first Esperion was founded in 1998 by Dr. Roger Newton to focus on the in-licensing and development of drugs to modulate HDL cholesterol (HDL-c). [citation needed] Pfizer acquired …See details»
Esperion - LinkedIn
At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases. The …See details»
Sheldon Koenig of Esperion: Lessons I Learned From Last Year
Mar 18, 2025 Esperion Therapeutics, Inc., is a commercial-stage biopharmaceutical company focused on bringing new medicines to market that address unmet needs of patients and …See details»
Esperion - Crunchbase Company Profile & Funding
Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on …See details»
Esperion Therapeutics - Leadership Team - The Org
The Leadership Team at Esperion Therapeutics drives the strategic direction and operational excellence essential for advancing the company's mission to develop innovative LDL-C …See details»
Esperion Company Profile | Management and Employees List
Esperion Profile and History. Esperion was founded in 2008. Since then, our teams have worked diligently to discover, develop, and commercialize innovative medicines to help improve …See details»
An evolution in leadership and vision for this pharma company
Jan 6, 2025 For those who are unable to attend, our presentation will be available to anyone through a link on esperion.com. Esperion discovers, develops and commercializes innovative …See details»
ESPERION Appoints Sheldon Koenig as President and CEO
May 17, 2021 ESPERION Therapeutics ESPERION is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines easy …See details»
Esperion Corporate Presentation
Profitability, and growth of Esperion’s commercial products, clinical activities and results, supply chain, commercial development and launch plans, the outcomes and anticipated benefits of …See details»
Esperion at The Citizens JMP Life Sciences Conference: Strategic …
2 days ago On Thursday, 08 May 2025, Esperion Therapeutics Inc. (NASDAQ:ESPR) presented at The Citizens JMP Life Sciences Conference 2025, highlighting its strategic initiatives and …See details»
Esperion Company Overview, Contact Details & Competitors
Jun 21, 2019 Esperion Therapeutics, Inc. (NASDAQ:ESPR ) Q4 2024 Earnings Conference Call March 4, 2025 8:00 AM ET Company Participants Alina Venezia - Director of Investor …See details»
ESPERION CORPORATE PRESENTATION - Seeking Alpha
Condition, the net sales, profitability, and growth of Esperion’s commercial products, clinical activities and results, supply chain, commercial development and launch plans, and the risks …See details»
Working at Esperion - Great Place To Work®
79% of employees at Esperion say it is a great place to work . ... Today, our Trust Modelâ„¢ offers an unmatched opportunity to identify what’s happening within your organization. Great Place …See details»
Esperion Therapeutics
Mar 20, 2025 The first Esperion was founded in 1998 by Dr. Roger Newton to focus on the in-licensing and development of drugs to modulate HDL cholesterol .Pfizer acquired the original …See details»
Esperion Launches New Scientific Website - Yahoo Finance
Feb 24, 2023 Designed Specifically for the Scientific and Medical Communities, esperionscience.com Features Information about Esperion’s Landmark CLEAR Outcomes …See details»
Esperion names new president, CEO – TechCentury
May 17, 2021 ANN ARBOR—Esperion Therapeutics Inc. (Nasdaq: ESPR) announced the appointment of Sheldon Koenig as president, CEO, and board member, effective immediately. …See details»
Mission, Vision & Core Values of Esperion – …
Oct 2, 2024 Esperion is a forward-thinking pharmaceutical company dedicated to revolutionizing the field of lipid management and cardiovascular health. ... Furthermore, we are committed to …See details»
Esperion Enters License Agreement with HLS Therapeutics to
2 days ago Esperion Therapeutics, Inc. is a commercial stage biopharmaceutical company focused on bringing new medicines to market that address unmet needs of patients and …See details»
Esperion Reports First Quarter 2025 Financial Results
4 days ago Esperion Contact Information: Investors: Alina Venezia [email protected] (734) 887-3903. Media: Tiffany Aldrich …See details»